Omega-3 Fatty Acids: Reversing Damage Post-Heart Attack

According to the Centers for Disease Control and Prevention (CDC), there are about 600,000 people that die from heart disease every year in the U.S. In fact, heart disease is the leading cause of death for both men and women. Unfortunately heart disease can ultimately result in heart attacks, which can be fatal.

Every year roughly 720,000 Americans have a heart attack.

Even though your doctor may recommend exercise and changing your eating habits, what about the damage that's already been done. Can it be reversed?

For example, inflammation after a heart attack can bring on further damage to your heart muscle, which could lead to ventricular arrhythmias and can cause another heart attack, stroke, or other problems.

Is incorporating omega-3 fatty acids into your diet the answer?

Bill Harris, PhD, joins Dr. Mike to discuss your heart health and the important role omega-3 fatty acids play in reversing the damage.
Omega-3 Fatty Acids: Reversing Damage Post-Heart Attack
Featured Speaker:
Dr Bill HarrisDr. Bill Harris is an internationally recognized expert on omega-3 fatty acids and how they can benefit patients with heart disease.

He obtained his PhD in Human Nutrition from the University of Minnesota, and did post-doctoral fellowships in Clinical Nutrition and Lipid Metabolism with Dr. Bill Connor at the Oregon Health Sciences University. His interest in omega-3 fatty acids began with his postdoctoral work when he published his first study on the effects of salmon oil on serum lipids in humans (1980).

Since that time he has been the recipient of five NIH grants for studies on the effects of omega-3 fatty acids (EPA and DHA) on human health. He has over 190 publications relating to omega-3 fatty acids in medical literature and was an author on two American Heart Association scientific statements on fatty acids: "Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease" (2002), and "Omega-6 Fatty Acids and Risk for Cardiovascular Disease" (2009) both published in the journal Circulation.

Dr. Harris is a Senior Scientist at Health Diagnostic Laboratory; a Professor in the Department of Medicine, Sanford School of Medicine, University of South Dakota; and the President and CEO of OmegaQuant.